Rituximab therapy for childhood-onset systemic lupus erythematosus
- 1 May 2006
- journal article
- research article
- Published by Elsevier in The Journal of Pediatrics
- Vol. 148 (5) , 623-627.e3
- https://doi.org/10.1016/j.jpeds.2006.01.041
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Initial presentation of childhood-onset systemic lupus erythematosus: A French multicenter studyThe Journal of Pediatrics, 2005
- Anti-CD20 therapy in systemic lupus erythematosus: A step closer to the clinicArthritis & Rheumatism, 2005
- Remission of proliferative lupus nephritis following B cell depletion therapy is preceded by down‐regulation of the T cell costimulatory molecule CD40 ligand: An open‐label trialArthritis & Rheumatism, 2005
- B cell abnormalities in systemic lupus erythematosusArthritis Research & Therapy, 2003
- Treating human autoimmune disease by depleting B cellsAnnals of the Rheumatic Diseases, 2002
- Treatment Options for Juvenile-Onset Systemic Lupus ErythematosusPediatric Drugs, 2002
- Rituximab: mechanisms and applicationsBritish Journal of Cancer, 2001
- Systemic lupus erythematosus: an autoimmune disease of B cell hyperactivityNature Immunology, 2001
- A Novel Mouse with B Cells but Lacking Serum Antibody Reveals an Antibody-independent Role for B Cells in Murine LupusThe Journal of Experimental Medicine, 1999
- Immunological and clinical differences between juvenile and adult onset of systemic lupus erythematosusLupus, 1999